A Phase I/II Study of tgAAV-CF for the Treatment of Chronic Sinusitis in Patients with Cystic Fibrosis. Stanford University, Stanford, California
- 10 April 1998
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 9 (6), 889-909
- https://doi.org/10.1089/hum.1998.9.6-889
Abstract
The only peer-reviewed journal focused on the rapidly moving field of 3D printing and related technologies, providing comprehensive coverage of academic research and industrial and commercial developments that have applications in medicine, education, food, and architecture.This publication has 11 references indexed in Scilit:
- Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosisNature Genetics, 1994
- Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.Proceedings of the National Academy of Sciences of the United States of America, 1993
- Pathogenesis of cystic fibrosisThe Lancet, 1993
- Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter.Journal of Biological Chemistry, 1993
- The changing epidemiology of cystic fibrosisThe Journal of Pediatrics, 1993
- Adeno-associated virus vectorsCurrent Opinion in Biotechnology, 1992
- Simple SAS macros for the calculation of exact binomial and Poisson confidence limitsComputers in Biology and Medicine, 1992
- Impact of sinusitis in cystic fibrosisJournal of Allergy and Clinical Immunology, 1992
- Defective regulation of outwardly rectifying Cl− channels by protein kinase A corrected by insertion of CFTRNature, 1992
- Asymptotic and Exact Power for the McNemar Test and Its Analogue with R Controls Per CasePublished by JSTOR ,1984